Concepedia

Mandy M. T. van Leent

MM

22

Publications

1.5K

Citations

18

H-Index

2018

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Eindhoven University of Technology

Radboud University Medical Center

Radboud University Nijmegen

Amsterdam University Medical Centers

Mandy M. T. van Leent is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, nanomedicine, and immunology.

ORCID

Top concepts

Publications per year

2018–2024

22

Publications

22

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance

Mounia S. Braza, Mandy M. T. van Leent, Marnix Lameijer et al. · Immunity · 2018 · 241 citations · Full text

, , +9

Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition

Bram Priem, Mandy M. T. van Leent, Abraham J. P. Teunissen et al. · Cell · 2020 · 194 citations · Full text

, , +12

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis

Kikkie Poels, Mandy M. T. van Leent, C. Boutros et al. · JACC CardioOncology · 2020 · 132 citations · Full text

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates

Marnix Lameijer, Tina Binderup, Mandy M. T. van Leent et al. · Nature Biomedical Engineering · 2018 · 125 citations

, , +10

Tumor Targeting by α<sub>v</sub>β<sub>3</sub>-Integrin-Specific Lipid Nanoparticles Occurs <i>via</i> Phagocyte Hitchhiking

Alexandros Marios Sofias, Yohana C. Toner, Anu E. Meerwaldt et al. · ACS Nano · 2020 · 107 citations · Full text

Rows per page

1–5 of 22